Role of Circulating Tumor DNA in Gastrointestinal Cancers: Current Knowledge and Perspectives
Gastrointestinal (GI) cancers are major health burdens worldwide and biomarkers are needed to improve the management of these diseases along their evolution. Circulating tumor DNA (ctDNA) is a promising non-invasive blood and other bodily-fluid-based biomarker in cancer management that can help clin...
Main Authors: | Emilie Moati, Valerie Taly, Simon Garinet, Audrey Didelot, Julien Taieb, Pierre Laurent-Puig, Aziz Zaanan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/19/4743 |
Similar Items
-
The Position of Circulating Tumor DNA in the Clinical Management of Colorectal Cancer
by: Ana Regina de Abreu, et al.
Published: (2023-02-01) -
Circulating MicroRNAs in Gastrointestinal Cancer
by: Masahisa Ohtsuka, et al.
Published: (2021-07-01) -
Progress in application of peritoneal lavage fluid circulating tumor DNA to predicting peritoneal metastasis of gastrointestinal cancer
by: BAI Long, et al.
Published: (2023-12-01) -
Circulating MicroRNAs: Molecular Microsensors in Gastrointestinal Cancer
by: Moisés Blanco-Calvo, et al.
Published: (2012-07-01) -
<em>BRAF</em> Mutation Status in Circulating Tumor DNA from Patients with Metastatic Colorectal Cancer: Extended Mutation Analysis from the AGEO RASANC Study
by: Leo Mas, et al.
Published: (2019-07-01)